Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
How many shares should you buy? The answer requires a little simple math. Shares of AbbVie were recently trading for $212 apiece, and the company's total annual dividend amount (paid out over four quarters, like most dividend payers) is currently $6.56. The dividend might go up or down, but that's what it is as I write this. If you're looking to collect $1,000, simply divide that $1,000 by $6.56. You'll get 152, which is the number of shares you'd need to own for a year to get $1,000 in dividend payments. At the recent share price, that would cost you $32,224. Hmm...that might be a tall order for you. It would be for most Americans. Even if you could swing it by putting most of your portfolio into AbbVie, you'd then have too many eggs in that one basket. So consider including some other promising dividend stocks in your mix. Note, too, that like many healthy and growing dividend payers, AbbVie has been hiking its payout annually. So if you only buy enough to collect, say, $300
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise [Seeking Alpha]Seeking Alpha
- Abbott Laboratories (NYSE:ABT) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Is Abbott Laboratories Attractively Priced After Recent Share Price Gains And DCF Concerns? [Yahoo! Finance]Yahoo! Finance
- Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation [Yahoo! Finance]Yahoo! Finance
- Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial FibrillationPR Newswire
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/23/25 - Form 3
- 12/19/25 - Form 3
- 12/12/25 - Form 4
- ABT's page on the SEC website